BCM
BIOS Capital Management Portfolio holdings
AUM
$72.6M
This Quarter Return
-10.71%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$72.6M
AUM Growth
+$72.6M
(-8.3%)
Cap. Flow
-$14.8M
Cap. Flow
% of AUM
-20.43%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
2
Reduced
2
Closed
–
Top Buys
| 1 |
IRD
Opus Genetics, Inc. Common Stock
IRD
|
$2.53M |
| 2 |
ACTU
Actuate Therapeutics, Inc. Common stock
ACTU
|
$436K |
Top Sells
| 1 |
IN8bio
INAB
|
$17.4M |
| 2 |
Lantern Pharma
LTRN
|
$416K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACTU
1
Actuate Therapeutics, Inc. Common stock
ACTU
$175M
| $60.9M | 83.89% | 9,965,079 +71,428 | +0.7% | +$436K |
|
|
IRD
2
Opus Genetics, Inc. Common Stock
IRD
$73.1M
| $3.46M | 4.77% | 3,683,429 +2,688,180 | +270% | +$2.53M |
|
|
3
Lantern Pharma
LTRN
$44.1M
| $3.4M | 4.68% | 1,075,952 -131,757 | -11% | -$416K |
|
|
RNTX
4
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
| $2.37M | 3.26% | 1,690,751 | – | – |
|
5
Cognition Therapeutics
CGTX
$179M
| $1.86M | 2.56% | 6,000,000 | – | – |
|
|
6
IN8bio
INAB
$10M
| $599K | 0.83% | 286,664 -8,313,337 | -97% | -$17.4M |
|